Forterra plc Director Declaration (5640O)
February 01 2023 - 2:18AM
UK Regulatory
TIDMFORT
RNS Number : 5640O
Forterra plc
01 February 2023
1 February 2023
Forterra plc
Director Declaration
Pursuant to Listing Rule 9.6.14(2) Forterra plc (the "Company")
announces that Martin Sutherland, a Non-Executive of the Company,
with effect from 1 February 2023 has been appointed as a
Non-Executive Director of Alliance Pharma plc, a company listed on
the London Stock Exchange AIM market.
Enquiries:
Forterra plc +44 (0) 1604 707 600
Ashley Thompson (Company Secretary)
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RDNNKDBDFBKKABK
(END) Dow Jones Newswires
February 01, 2023 03:18 ET (08:18 GMT)
Forterra (LSE:FORT)
Historical Stock Chart
From Apr 2024 to May 2024
Forterra (LSE:FORT)
Historical Stock Chart
From May 2023 to May 2024